# Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers

> **NCT03691584** · PHASE1 · COMPLETED · sponsor: **Tetraphase Pharmaceuticals, Inc** · enrollment: 8 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** TP-6076
- **PROCEDURE:** Bronchoalveolar lavage

## Key facts

- **NCT ID:** NCT03691584
- **Lead sponsor:** Tetraphase Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-26
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-12-18
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03691584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03691584, "Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03691584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*